CCL3 and cancer: Regarding the key interaction between T cells and cancer cells, increased expression of ligand-receptor pairs MIF_TNFRSF10D, CD55_ADGRE5, CD226_NECTIN2, CCL3L1_CCR1, and CCL3_CCR1 was observed (Figure 5M).